Drug pricing conversations must take the cost of innovation into consideration
ALEX WONG/GETTY IMAGES
Legislation to lower drug prices may be good for today, but it can undermine incentives to invest in developing tomorrow's innovative products.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario